Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk

Carcinogenesis

Volumn 21, Issue 2, 2000, Pages 189-193

  Healey, Catherine S ^a   Dunning, Alison M ^a   Durocher, Francine ^a   Teare, Dawn ^a   Pharoah, Paul D P ^a   Luben, Robert N ^a   Easton, Douglas F ^a   Ponder, Bruce A J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANDROGEN; AROMATASE; CYTOCHROME P450; ESTROGEN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; INTRON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0033952441     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.2.189     Document Type: Article

References (26)

1. Claus, E.B., Risch, N. and Thompson, W.D. (1991) Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am. J. Hum. Genet., 48, 232-242.
2. Ford, D. and Easton, D.F. (1995) The genetics of breast and ovarian cancer. Br. J. Cancer, 72, 805-812.
3. Pike, M.C., Spicer, D.V., Dahmoush, L. and Press, M.F. (1993) Estrogens, progestogens, normal breast cell proliferation and breast cancer risk. Epidemiol. Rev., 15, 17-35.
4. Henderson, B.E. and Bernstein, L. (1996) Endogenous and exogenous hormone factors. In Harris, J.R. (ed). Diseases and the Breast. Lippincott-Raven, Philidelphia, PA, pp. 185-200.
5. Toniolo, P.G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K.L., Shore, R.E., Strax, P. and Pastenack, B.A. (1995) A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl Cancer Inst., 87, 190-197.
6. O'Neill, J.S., Elton, R.A. and Miller, W.R. (1988) Aromatase activity in adipose tissue from breast quadrants: a link with tumour site. Br. Med. J., 296, 741-743.
7. Bulun, S.E., Price, T.M., Mahendroo, M.S., Aitken, J. and Simpson, E.R. (1993) A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J. Clin. Endocrinol. Metab., 17, 1622-1628.
8. Bulun, S.E. and Simpson, E.R. (1994) Regulation of the CYP19 (P450arom) gene expression in breast adipose tissue and breast cancer. Trends Endocrinol. Metab., 5, 113-120.
9. Corbin, C.J., Graham-Lorence, S., McPhaul, M., Manson, J.I., Mendelson, C.R. and Simpson, E.R. (1988) Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells. Proc. Natl Acad. Sci. USA, 85, 8948-8952.
10. Bershtein, L.M. (1997) Molecular-genetic aspects of estrogen production. Aromatase gene. Mol. Biol., 31, 655-659.
11. Harada, N., Ogawa, H., Shozu, M. and Yamada, K. (1992) Genetic studies to characterize the origin of the mutation in placental aromatase deficiency. Am. J. Hum. Genet., 51, 666-672.
12. Ito, Y., Fisher, C.R., Conte, F.A., Grumbach, M.M. and Simpson, E.R. (1993) Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc. Natl Acad. Sci. USA, 90, 11673-11677.
13. Morishima, A., Grumbach, M.M., Simpson, E.R., Fisher, C. and Qin, K. (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab., 80, 3689-3698.
14. Mullis, P.E., Yoshimura, N., Kuhlmann, B., Lippuner, K., Jaeger, P. and Harada, H. (1997) Aromatase deficiency in a female who is compound heterozygole for two new point mutations in the P450 arom gene: impact of estrogens on hypergonadotrophic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J. Clin. Endocrinol. Metab., 82, 1739-1745.
15. Polymeropoulos, M.H., Xiao, H., Rath, D.S. and Merril, C.R. (1991) Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19). Nucleic Acids Res., 19, 195.
16. Means, G.D., Mahendroo, M.S., Corbin, C.J., Mathis, J.M., Powell, F.E., Mendelson, C.R. and Simpson, E.R. (1989) Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J. Biol. Chem., 264, 19385-19391.
17. Sourdaine, P., Parker, M.G., Telford, J. and Miller, W.R. (1994) Analysis of the aromatase cytochrome P450 gene in human breast cancers. J. Mol. Endocrinol., 13, 331-337.
18. Watanabe, J., Harada, N., Suemasu, K., Higashi, Y., Gotoh, O. and Kawajiri, K. (1997) Arginine-cysteine polymorphism at codon 264 of the human CYP19 gene does not affect aromatase activity. Pharmacogenetics, 7, 419-424.
19. Kristensen, V.N., Andersen, T.I., Lindblom, A., Erikstein, B., Magnus, P. and Borresen-Dale, A.-L. (1998) A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics, 8, 43-48.
20. Haiman, C.A., Hankinson, S.E., Speizer, F.E. and Hunter, D.J. (1999) A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Proc. Am. Assoc. Cancer Res., 40, A. 1290.
21. Siegelmann-Danieli, N. and Buetow, K.H. (1999) Constitutional genetic variation at the human aromatase gene (CYP19) and breast cancer. Br. J. Cancer, 79, 456-463.
22. Day, N., Oakes, S., Luben, R., Khaw, K.-T., Bingham, S., Welch, A. and Warcham, N. (1999) EPIC in Norfolk: study design and characteristics of the cohort. Br. J. Cancer, 80, 95-103.
23. Chakravarti, A., Buetow, K.H., Antonarakis, S.E., Waber, P.G., Boehm, C.D. and Kazazian, H.H. (1984) Nonuniform recombination within the human β-globin gene cluster. Am. J. Hum. Genet., 36, 1239-1258.
24. Kurosaki, K., Saitoh, H., Oota, H., Watanabe, Y., Kiuchi, M. and Ueda, S. (1997) Combined polymorphism associated with a 3-bp deletion in the 5′-flanking region of a tetrameric short tandem repeat at the CYP19 locus. Jpn. J. Legal Med., 51, 191-195.
25. Mahendroo, M.S., Mendelson, C.R. and Simpsom, E.R. (1993) Tissue-specific and hormonally-controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J. Biol. Chem., 268, 19463-19470.
26. Agarwal, V.R., Bulun, S.E., Leitch, M., Rohrich, R. and Simpson, E.R. (1996) Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J. Clin. Endocrinol. Metab., 81, 3843-3849.